Beta-Blocker Therapy and Cardiac Events Among Patients With Newly Diagnosed Coronary Heart Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Beta-Blocker Therapy and Cardiac Events Among Patients With Newly Diagnosed Coronary Heart Disease

Published:2014-07 Issue:3 Volume:64 Page:247-252
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Andersson Charlotte,Shilane David,Go Alan S.,Chang Tara I.,Kazi Dhruv,Solomon Matthew D.,Boothroyd Derek B.,Hlatky Mark A.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference22 articles.

1. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial;Lancet,1999

2. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF);Lancet,1999

3. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial;Dargie;Lancet,2001

4. Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial;Hjalmarson;Lancet,1981

5. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study;Packer;Circulation,2002

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimal Medical Therapy for Stable Ischemic Heart Disease;Medical Clinics of North America;2024-05

2. Mortality of patients presented with acute ST-segment elevation myocardial infarction according to the status of standard modifiable cardiovascular risk factors;The American Journal of the Medical Sciences;2024-05

3. Comparison of β-blocker agents and mortality in maintenance hemodialysis patients: an international cohort study;Clinical Kidney Journal;2024-03-27

4. Do Clinical Outcomes and Quality of Life Differ by the Number of Antianginals for Stable Ischemic Heart Disease? Insights from the BARI 2D Trial;The American Journal of Cardiology;2024-03

5. World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease: 2023 Update;Global Heart;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3